 |
 |
About Scripps Research
Facts-at-a-Glance
General Information
The Scripps Research Institute is the world's largest, private
non-profit biomedical research facility. Since its founding in
1961 by a small group of immunopathologists led by Frank Dixon,
M.D., the Institute has become internationally recognized for
its basic research into immunology, molecular biology, cell biology,
chemistry, neurosciences, autoimmune diseases, cardiovascular
disorders, and cancer research. Currently housed in laboratory
buildings with more than 1,000,000 square feet of space overlooking
the Pacific Ocean in La Jolla, its staff numbers some 2,800, with
289 faculty members, nearly 815 postdoctoral fellows, 235 graduate
students, and over 1,500 technical and administrative support
personnel.
Researchers at the Institute pursue scientific inquiry in seven primary
fields of study each organized into a separate department: cell biology,
chemistry, immunology, molecular biology, molecular and experimental
medicine, neurobiology, and neuropharmacology, in addition
to The Skaggs Institute for Chemical Biology, the Harold L. Dorris
Neurological Research Center, the Institute for Childhood and Neglected
Diseases, and the Center for Integrative Molecular Biosciences. While the nature of the work at Scripps Research is basic and aimed at the
discovery of fundamental knowledge, research in these fields continues to
have significant ramifications for stroke and heart disease, cancer,
neurological disorders, viral diseases, alcoholism and chemical dependency,
diabetes, autoimmune diseases, and kidney dysfunction.
Faculty
There are 225 members of the faculty at Scripps Research. Widely recognized
in the international scientific arena, many are the recipients
of prestigious honors and awards, including the following:
Nobel Laureates
Gerald M. Edelman, M.D., Ph.D.
K. Barry Sharpless, Ph.D.
Kurt Wüthrich, Ph.D.
Members, National Academy of Sciences
Bruce Beulter, M.D.
Ernest Beutler, M.D.
Floyd E. Bloom, M.D.
Francis V. Chisari, M.D.
Gerald M. Edelman, M.D., Ph.D.
Albert Eschenmoser, Ph.D.
Gerald F. Joyce, M.D., Ph.D.
Richard A. Lerner, M.D.
K.C. Nicolaou, Ph.D.
Michael B.A. Oldstone, M.D.
Julius Rebek, Jr., Ph.D.
Paul Schimmel, Ph.D.
Peter Schultz, Ph.D.
K. Barry Sharpless, Ph.D.
Peter K. Vogt, Ph.D.
Charles Weissmann, M.D., Ph.D.
Chi-Huey Wong, Ph.D.
Peter Wright, Ph.D.
Kurt Wüthrich, Ph.D.
Members, National Institute of Medicine
Floyd E. Bloom, M.D.
Francis V. Chisari, M.D.
Thomas S. Edgington, M.D.
Richard A. Lerner, M.D.
Michael B. Oldstone, M.D.
Peter Schultz, Ph.D.
Eric J. Topol, M.D.
Peter K. Vogt, PH.D.
Members, American Academy of Arts and Sciences
Ernest Beutler, M.D.
Floyd E. Bloom, M.D.
Dale L. Boger, Ph.D.
Gerald M. Edelman, M.D., Ph.D.
Richard A. Lerner, M.D.
K.C. Nicolaou, Ph.D.
Julius Rebek, Jr., Ph.D.
Paul Schimmel, Ph.D.
Peter Schultz, Ph.D.
K. Barry Sharpless, Ph.D.
Peter K. Vogt, Ph.D.
Charles Weissmann, M.D., Ph.D.
Ian W. Wilson, Ph.D.
Chi-Huey Wong, Ph.D.
Peter E. Wright, Ph.D.
Kurt Wüthrich, Ph.D.
Members, American Philosophical Society
Floyd E. Bloom, M.D.
Gerald M. Edelman, M.D., Ph.D.
Paul Schimmel, Ph.D.
Peter Vogt, Ph.D.
Fellows, American Association for the Advancement of Science
Dale L. Boger, Ph.D.
Charles L. Brooks, III, Ph.D.
Michael Buchmeier, Ph.D.
Gerald M. Edelman, M.D., Ph.D.
Thomas S. Edgington, M.D.
M. Reza Ghadiri, Ph.D.
Kim D. Janda, Ph.D.
George Koob, Ph.D.
Richard A. Lerner, M.D.
Donald E. Mosier, M.D., Ph.D.
K.C. Nicolaou, Ph.D.
Michael B. Oldstone, M.D.
Julius Rebek, Jr., Ph.D.
Paul Schimmel, Ph.D.
Sandra L. Schmid, Ph.D.
K. Barry Sharpless, Ph.D.
Eng M. Tan, M.D.
Peter E. Wright, Ph.D.
Recipients, Wolf Prize in Chemistry
Albert Eschenmoser, Ph.D.
Richard A. Lerner, M.D.
Peter Schultz, Ph.D.
K. Barry Sharpless, Ph.D.
Recipients, California Scientist of the Year Award
Richard A. Lerner, M.D.
Peter Schultz, Ph.D.
Peter K. Vogt, Ph.D.
Faculty by Department - California
| Cell Biology |
23 |
| Chemical Physiology |
8 |
| Chemistry |
23 |
| Committee on the Neurobiology of Addictive Disorders |
7 |
| Genetics |
1 |
| Immunology |
34 |
| Molecular Biology |
38 |
| Molecular & Experimental Medicine |
34 |
| Molecular & Integrative Neuroscience |
20 |
| Neurobiology |
6 |
Faculty and Professional Staff - Florida
| Cancer Biology |
12 |
| Chemistry |
6 |
| Infectology |
8 |
| Molecular & Integrative Neurosciences |
1 |
| Molecular Therapeutics |
8 |
| Translational Research Institute |
23 |
Employees
| California |
| Faculty |
Research Associates |
Graduate Students |
Technical & Support Services Employees |
| 229 |
686 |
263 |
1277 |
| Florida |
| Faculty & Professional Staff |
Research Associates |
Graduate Students |
Technical & Support Services Employees |
| 58 |
59 |
17 |
112 |
Education Programs
Postdoctoral Fellows
TSRI has maintained its
commitment to training the next generation of scientists, in part, by its
active recruitment of postdoctoral fellows, all of whom have completed
postgraduate degrees. They continue their scientific training in TSRI's
laboratories for a period of two to five years under the supervision of the
senior scientific staff. They contribute to ongoing research inquiries and
are named authors on numerous scientific publications.
Ph.D. Graduate Education
Because most of the important
problems in biology and chemistry today require an interdisciplinary
approach in their solutions, the Ph.D. graduate program in Macromolecular
and Cellular Structure and Chemistry (MCSC) was established in
1989 to integrate such disciplines as cell and molecular biology,
structure and chemistry. And, in an effort to draw on the superior
capabilities of the chemistry faculty with a record of achievement
in contemporary areas of chemical, biological and structural research,
a doctoral program in Chemistry was established three years later.
These five-year programs lead to the Ph.D. degree and provide
training for a select group of outstanding and intellectually
diverse students.
In 2002, TSRI named its graduate college The Kellogg School of Science
and Technology for philanthropists Janet R. (“Jean”) and
W. Keith Kellogg II, who have been long-standing patrons of education
and science.
In 2003, a comprehensive review of the curriculum resulted in the
redefined Doctoral Program in Chemical and Biological Sciences emphasizing
the interdisciplinary nature of the program and reflecting the particular
strengths of the Institue. This change allows students to select one
of four curricular tracks—chemistry, chemical biology, biophysics
or biology—and acknowledges the faculty's and student's views that
future scientists must be broadly trained in these areas of scientific
inquiry.
For the last two years, the Graduate Studies Program was ranked by U.S. News & World Report in the top ten of the most outstanding in the country, based
on the results of a survey sent to department heads and directors of
graduate studies programs at universities throughout the country.
Educational Outreach
TSRI has a local and national
commitment to guide young students and provide them with opportunities to
explore and pursue educational and career opportunities in the sciences.
Toward this end, funded through grants and private philanthropy, the
Institute provides a variety of programs for students at the high school
and college levels and for middle school and high school science teachers
to participate in research activities on the campus. These programs are
designed and supervised by many of TSRI's graduate students and senior
scientists. While students of all ethnic and cultural groups are accepted
into the programs, a special emphasis is placed on identifying and
recruiting students who are historically underrepresented in the
sciences.
Campus
Facilities
Scripps Research's facilities are located on approximately 35 acres of land of which
14.7 are owned by The Scripps Research Institute. The campus is within close proximity to the
University of California, San Diego, in La Jolla, California. This
location provides access to San Diego's scientific community, which
includes The Salk Institute and the Burnham Institute, as well as a
concentration of some 300 biotechnology companies.
The campus includes leased and owned space. TSRI owns facilities,
including approximately 410,500 square feet of laboratory space.
Additionally the Institute leases some 573,500 square feet of laboratory
space in 12 buildings and approximately 60,800 square feet of
administrative space in three buildings.
Technical Support Capabilities
The research activities of TSRI's scientists require significant
technical support, including research computing, NMR spectroscopy, particle
beam spectroscopy, mass spectroscopy, optical spectroscopy, a fluorescence
activated cell sorting facility, x-ray crystallography laboratories,
electron microscopy, bioinformatics, and DNA array protein chip technology.
NMR spectrometers are housed in the Aline W. and L.S. Skaggs NMR Building
and the Buddy Taub Center for Molecular Structure and Design.
Computer and Network Facilities
The Institute maintains a comprehensive data network with computational and data archive facilities to
meet researcher's needs. For an up-to-date list of our computer and network facilities go to: http://www.scripps.edu/rc/compfac.html
Finance
Financial Statements for years ended
September 30, 2007 and 2006 (pdf)
Grants and contracts provide funding for a significant portion of
TSRI's research activities. This revenue is derived primarily from the
National Institutes of Health and other federal agencies. Grantors
include, among others, the American Cancer Society, the American Heart
Association, the American Lung Association, and the Juvenile Diabetes
Association. In addition, TSRI currently enjoys a large-scale industrial
collaboration agreement with Novartis Pharmaceuticals Corporation.
Technology transfer activities — royalties and gains from the sale of
equity securities received in exchange for technology licenses and
corporate funding agreements — fund raising activities, and
investments provide resources for new programs, recruitment of new
scientists and internally supported research.
Gifts from individuals and private foundation provide an important
source of funding for TSRI. Private foundations that have provided support
include the ALSAM Foundation, Lucille P. Markey Charitable Trust, G. Harold
and Leila Mathers Charitable Foundation, W.M. Keck Foundation, Arnold and
Mabel Beckman Foundation, Pew Charitable Trusts, Harold L. Dorris
Foundation, and the Rockefeller Foundation.
Sponsored Research
| |
NIH
|
Federal Agencies
|
Other
|
Total
|
| 2007 |
$230,320,000 |
$8,215,000 |
$58,165,000 |
$296,700,000 |
| 2006 |
$230,523,000 |
$8,629,000 |
$72,289,000 |
$311,441,000 |
| 2005 |
$223,186,000 |
$9,086,000 |
$80,506,000 |
$312,778,000 |
| 2004 |
$219,961,000 |
$12,028,000 |
$28,282,000 |
$265,221,000 |
| 2003 |
$196,304,000 |
$11,824,000 |
$34,321,000 |
$242,449,000 |
| 2002 |
$173,816,000 |
$11,716,000 |
$38,904,000 |
$224,436,000 |
| 2001 |
$144,273,000 |
$9,735,000 |
$39,400,000 |
$193,408,000 |
| 2000 |
$131,531,000 |
$8,173,000 |
$39,592,000 |
$179,296,000 |
| 1999 |
$120,220,000 |
$5,959,000 |
$34,421,000 |
$160,600,000 |
| 1998 |
$106,946,000 |
$6,240,000 |
$33,381,000 |
$146,567,000 |
| 1997 |
$95,931,000 |
$6,401,000 |
$28,690,000 |
$131,022,000 |
| 1996 |
$87,266,000 |
$5,114,000 |
$25,205,000 |
$117,585,000 |
| 1995 |
$88,582,000 |
$5,168,000 |
$15,398,000 |
$109,148,000 |
Net Income
|
|
Total
|
|
2007
|
$41,536,000 |
|
2006
|
$63,285,000 |
|
2005
|
$63,372,000 |
|
2004
|
$39,741,000 |
|
2003
|
$25,152,000 |
|
2002
|
($26,026,000) |
|
2001
|
($39,492,000) |
|
2000
|
$33,915,000 |
|
1999
|
$31,036,000 |
|
1998
|
$7,546,000 |
|
1997
|
$42,303,000 |
|
1996
|
$26,397,000 |
|
1995
|
$24,823,000 |
Total Assets
| |
Investments |
Property
|
Other Assets
|
Total
|
|
2007
|
$379,789,000 |
$292,033,000 |
$96,123,000 |
$767,945,000 |
|
2006
|
$330,405,000 |
$226,254,000 |
$75,614,000 |
$632,273,000 |
| 2005 |
$278,245,000 |
$226,816,000 |
$62,389,000 |
$567,450,000 |
| 2004 |
$258,244,000 |
$166,819,000 |
$28,910,000 |
$453,973,000 |
| 2003 |
$207,118,000 |
$169,911,000 |
$27,223,000 |
$404,252,000 |
| 2002 |
$180,585,000 |
$176,060,000 |
$23,930,000 |
$380,575,000 |
| 2001 |
$183,890,000 |
$184,607,000 |
$28,392,000 |
$396,889,000 |
| 2000 |
$242,920,000 |
$179,800,000 |
$21,382,000 |
$444,102,000 |
| 1999 |
$200,131,000 |
$168,289,000 |
$25,471,000 |
$393,891,000 |
| 1998 |
$184,837,000 |
$154,723,000 |
$21,584,000 |
$361,144,000 |
| 1997 |
$178,084,000 |
$154,599,000 |
$14,417,000 |
$347,100,000 |
| 1996 |
$145,978,000 |
$141,963,000 |
$11,550,000 |
$299,491,000 |
| 1995 |
$148,502,000 |
$124,595,000 |
$13,319,000 |
$286,416,000 |
Asset/Debt Ratio
|
|
Ratio
|
|
2007
|
13.43 |
|
2006
|
10.73 |
|
2005
|
9.36 |
|
2004
|
12.34 |
|
2003
|
10.60 |
|
2002
|
9.65
|
|
2001
|
9.76
|
|
2000
|
10.62
|
|
1999
|
14.61
|
|
1998
|
12.71
|
|
1997
|
11.54
|
|
1996
|
10.22
|
|
1995
|
9.55
|
Net Assets
|
|
Total
|
|
2007
|
$524,607,000 |
|
2006
|
$483,071,000 |
|
2005
|
$419,786,000
|
|
2004
|
$356,414,000
|
|
2003
|
$316,673,000
|
|
2002
|
$291,521,000
|
|
2001
|
$317,547,000
|
|
2000
|
$357,039,000
|
|
1999
|
$323,124,000
|
|
1998
|
$292,088,000
|
|
1997
|
$284,542,000
|
|
1996
|
$242,239,000
|
|
1995
|
$215,842,000
|
|
|
